Regulatory T cells protect against hypoxia-induced pulmonary arterial hypertension in mice

Molecular Medicine Reports

Volumn 11, Issue 4, 2015, Pages 3181-3187

  Chu, Yanbiao ^a,b   Xiangli, Xiaoying ^a   Xiao, Wei ^a  

^a SHANDONG UNIVERSITY   (China)

^b JINAN CENTRAL HOSPITAL AFFILIATED TO SHANDONG UNIVERSITY   (China)

Author keywords

Hypoxia; Proliferation; Pulmonary arterial hypertension; Regulatory T cells

Indexed keywords

CYCLIN D1; CYCLIN DEPENDENT KINASE 4; CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE; MONOCYTE CHEMOTACTIC PROTEIN 1; PROTEIN P27; AUTACOID; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, HUMAN; LIPID; PROTEIN KINASE B;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL CYCLE; CELL PROLIFERATION; CONTROLLED STUDY; HEART RIGHT VENTRICLE; HYPOXIA; IN VIVO STUDY; INFLAMMATION; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PULMONARY ARTERY; PULMONARY HYPERTENSION; QUANTITATIVE ANALYSIS; REGULATORY T LYMPHOCYTE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SMOOTH MUSCLE FIBER; SYSTOLIC BLOOD PRESSURE; VASCULAR REMODELING; WESTERN BLOTTING; ADOPTIVE TRANSFER; ANIMAL; ANOXIA; BLOOD; BODY WEIGHT; CELL CYCLE CHECKPOINT; DISEASE MODEL; HEMODYNAMICS; HUMAN; HYPERTENSION, PULMONARY; IMMUNOLOGY; METABOLISM; PATHOPHYSIOLOGY; PHOSPHORYLATION;

MUS;

ADOPTIVE TRANSFER; ANIMALS; ANOXIA; BODY WEIGHT; CELL CYCLE CHECKPOINTS; CELL PROLIFERATION; CYTOKINES; DISEASE MODELS, ANIMAL; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FORKHEAD TRANSCRIPTION FACTORS; HEMODYNAMICS; HUMANS; HYPERTENSION, PULMONARY; INFLAMMATION MEDIATORS; LIPIDS; MALE; MICE; MYOCYTES, SMOOTH MUSCLE; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; PULMONARY ARTERY; T-LYMPHOCYTES, REGULATORY;

EID: 84921395755     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2014.3106     Document Type: Article

References (32)

1. Gaine SP and Rubin LJ: Primary pulmonary hypertension. Lancet 352: 719-725, 1998.
2. Humbert M, Morrell NW, Archer SL, Stenmark KR, MacLean MR, Lang IM, Christman BW, Weir EK, Eickelberg O, Voelkel NF and Rabinovitch M: Cellular and molecular pathobiology of pulmonary arterial hypertension. J Am Coll Cardiol 43 (12 Suppl S): 13S-24S, 2004.
3. Owens GK, Kumar MS and Wamhoff BR: Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol Rev 84: 767-801, 2004.
4. Orlandi A, Bochaton-Piallat ML, Gabbiani G and Spagnoli LG: Aging, smooth muscle cells and vascular pathobiology: Implications for atherosclerosis. Atherosclerosis 188: 221-230, 2006.
5. Chen B, Calvert AE, Meng X and Nelin LD: Pharmacologic agents elevating cAMP prevent arginase II expression and proliferation of pulmonary artery smooth muscle cells. Am J Respir Cell Mol Biol 47: 218-226, 2012.
6. Stenmark KR, Fagan KA and Frid MG: Hypoxia-induced pulmonary vascular remodeling: Cellular and molecular mechanisms. Circ Res 99: 675-691, 2006.
7. Nicolls MR, Taraseviciene-Stewart L, Rai PR, Badesch DB and Voelkel NF: Autoimmunity and pulmonary hypertension: a perspective. Eur Respir J 26: 1110-1118, 2005.
8. Sakaguchi S: Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self. Nat Immunol 6: 345-352, 2005.
9. Meng X, Li W, Yang J, Zhang K, Qin W, An G, Gao F, Wang Y, Zhang C and Zhang Y: Regulatory T cells prevent plaque disruption in apolipoprotein E-knockout mice. Int J Cardiol 168: 2684-2692, 2013.
10. Ait-Oufella H, Wang Y, Herbin O, et al: Natural regulatory T cells limit angiotensin II-induced aneurysm formation and rupture in mice. Arterioscler Thromb Vasc Biol 33: 2374-2379, 2013.
11. Mor A, Planer D, Luboshits G, et al: Role of naturally occurring CD4+CD25+ regulatory T cells in experimental atherosclerosis. Arterioscler Thromb Vasc Biol 27: 893-900, 2007.
12. Yin M, Zhang J, Wang Y, et al: Deficient CD4+CD25+ T regulatory cell function in patients with abdominal aortic aneurysms. Arterioscler Thromb Vasc Biol 30: 1825-1831, 2010.
13. Guidi L, Felice C, Bonanno G, et al: FOXP3 T regulatory cell modifications in inflammatory bowel disease patients treated with anti-TNFα agents. Biomed Res Int 2013: 286368, 2013.
14. Oka M, Homma N, Taraseviciene-Stewart L, Morris KG, Kraskauskas D, Burns N, Voelkel NF and McMurtry IF: Rho kinase-mediated vasoconstriction is important in severe occlusive pulmonary arterial hypertension in rats. Circ Res 100: 923-929, 2007.
15. Lu X, Murphy TC, Nanes MS and Hart CM: PPAR{gamma} regulates hypoxia-induced nox4 expression in human pulmonary artery smooth muscle cells through NF-{kappa}B. Am J Physiol Lung Cell Mol Physiol 299: L559-L566, 2010.
16. Kim JM, Rasmussen JP and Rudensky AY: Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice. Nat Immunol 8: 191-197, 2007.
17. Fang K, Fu W, Beardsley AR, Sun X, Lisanti MP and Liu J: Overexpression of caveolin-1 inhibits endothelial cell proliferation by arresting the cell cycle at G0/G1 phase. Cell Cycle 6: 199-204, 2007.
18. Kraaij MD, Savage ND, van der Kooij SW, Koekkoek K, Wang J, van den Berg JM, Ottenhoff TH, Kuijpers TW, Holmdahl R, van Kooten C and Gelderman KA: Induction of regulatory T cells by macrophages is dependent on production of reactive oxygen species. Proc Natl Acad Sci USA 107: 17686-17691, 2010.
19. Hassoun PM, Mouthon L, Barberà JA, et al: Inflammation, growth factors, and pulmonary vascular remodeling. J Am Coll Cardiol 54 (1 Suppl): S10-S19, 2009.
20. El Chami H and Hassoun PM: Inflammatory mechanisms in the pathogenesis of pulmonary arterial hypertension. Compr Physiol 1: 1929-1941, 2011
21. Schober A and Zernecke A: Chemokines in vascular remodeling. Thromb Haemost 97: 730-737, 2007.
22. Itoh T, Nagaya N, Ishibashi-Ueda H, Kyotani S, Oya H, Sakamaki F, Kimura H and Nakanishi N: Increased plasma monocyte chemoattractant protein-1 level in idiopathic pulmonary arterial hypertension. Respirology 11: 158-163. 2006.
23. Steiner MK, Syrkina OL, Kolliputi N, Mark EJ, Hales CA and Waxman AB: Interleukin-6 overexpression induces pulmonary hypertension. Circ Res 104: 236-244, 2009.
24. Asadullah K, Sterry W and Volk HD. Interleukin-10 therapy - review of a new approach. Pharmacol Rev 55: 241-69, 2003.
25. Ito T, Okada T, Miyashita H, Nomoto T, Nonaka-Sarukawa M, Uchibori R, Maeda Y, Urabe M, Mizukami H, Kume A, Takahashi M, Ikeda U, Shimada K and Ozawa K: Interleukin-10 expression mediated by an adeno-associated virus vector prevents monocrotaline-induced pulmonary arterial hypertension in rats. Circ Res 101: 734-741, 2007.
26. Lavasani S, Dzhambazov B, Nouri M, et al: A novel probiotic mixture exerts a therapeutic effect on experimental autoimmune encephalomyelitis mediated by IL-10 producing regulatory T cells. PLoS One 5: e9009, 2010.
27. Owens GK: Regulation of differentiation of vascular smooth muscle cells. Physiol Rev 75: 487-517, 1995.
28. Luo Y, Xu DQ, Dong HY, Zhang B, Liu Y, Niu W, Dong MQ and Li ZC: Tanshinone iia inhibits hypoxia-induced pulmonary artery smooth muscle cell proliferation via akt/skp2/p27-associated pathway. PLoS One 8: e56774, 2013.
29. Yu L, Quinn DA, Garg HG and Hales C: Gene expression of cyclin-dependent kinase inhibitors and effect of heparin on their expression in mice with hypoxia-induced pulmonary hypertension. Biochem Biophys Res Commun 345: 1565-1572, 2006.
30. Dong Y, Sui L, Sugimoto K, Tai Y and Tokuda M: Cyclin d1-cdk4 complex, a possible critical factor for cell proliferation and prognosis in laryngeal squamous cell carcinomas. Int J Cancer 95: 209-215, 2001.
31. Sakamoto K, Ohki K, Saito M, Nakahara T and Ishii K: Small molecule cyclin-dependent kinase inhibitors protect against neuronal cell death in the ischemic-reperfused rat retina. J Ocul Pharmacol Ther 27: 419-425, 2011.
32. Toyoshima H and Hunter T: P27, a novel inhibitor of g1 cyclin-cdk protein kinase activity, is related to p21. Cell 78: 67-74, 1994.